Clinical Trials Sponsored by Sylentis, S.A.

Total 3174 results

Ferrer Internacional S.A.

Not yet recruiting

A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP)

Progressive Supranuclear Palsy
Biozeus Biopharmaceutical S.A.

Not yet recruiting

Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder

Female Sexual Dysfunction | Female Sexual Arousal Disorder
Glenmark Specialty S.A.

Recruiting

A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas.

Lymphoma | Advanced Solid Tumor

United States, India
Eurofarma Laboratorios S.A.

Not yet recruiting

Evaluation of Skin Irritancy and Sensitization of a Liquid Bandage

Skin Care

Brazil
Blau Farmaceutica S.A.

Not yet recruiting

Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration

Anticoagulant
Eurofarma Laboratorios S.A.

Not yet recruiting

Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil (FORASMA)

Moderate Asthma

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil (ALERZIN)

Allergic Rhinitis

Brazil
Eurofarma Laboratorios S.A.

Recruiting

Fixed-dose Combination of Oxycodone [OXIcodona] + IbuproFEN in Pain Relief After Third Molar Extraction (OXIFEN)

Pain

Brazil
ADC Therapeutics S.A.

Recruiting

A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)

B-Cell Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin Lymphoma

United States, Spain, Italy, United Kingdom, Belgium, Czechia
Philips Portuguesa S.A.

Not yet recruiting

Impact of Early Ventilation in Stroke Outcomes in Patients With Sleep Apnea After First Ever Stroke

Stroke | Sleep Apnea
Eurofarma Laboratorios S.A.

Active, not recruiting

Treatment of Androgenetic Alopecia in Men for 24 Weeks (MINOX)

Alopecia

Brazil
Tilman S.A.
Artialis

Completed

Effect and Tolerance of Standardized Exclusive Dry Extracts of Curcuma Longa and of Boswellia Serrata Among People With Hand Joint Discomfort and Dysfunction (CUBO)

Hand Joint Discomfort | Hand Joint Dysfunction

Belgium
Ferrer Internacional S.A.

Terminated

Study to Investigate the Long-term Safety of FAB122 in Patients With Amyotrophic Lateral Sclerosis (ADOREXT)

Amyotrophic Lateral Sclerosis

Spain
Steba Biotech S.A.

Completed

Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer

Prostate Cancer

United States
ADC Therapeutics S.A.

Completed

A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL) (LOTIS-9)

Diffuse Large B-cell Lymphoma

Spain, United States, Italy, Puerto Rico
Faes Farma, S.A.

Completed

Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency (WORFEROL)

Vitamin D Deficiency | Vitamin D Insufficiency

Spain, France, Bulgaria, Czechia, Italy, Serbia, Slovakia
Janssen-Cilag, S.A.

Completed

An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives

Depression

Mexico
Steba Biotech S.A.

Active, not recruiting

Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.

Localized Prostate Cancer

United States
SDS Optic S.A.

Completed

Safety and Efficacy Assessment of Diagnostic Microprobe (inPROBE) in Women at High Risk of Breast Cancer (Part I Study)

Breast Cancer

Poland
Apsen Farmaceutica S.A.

Completed

Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain (APS002/2020)

Low Back Pain | Low Back Pain, Mechanical | Acute Low Back Pain

Brazil
Polpharma Biologics S.A.

Completed

Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri® (Antelope)

Relapsing-Remitting Multiple Sclerosis (RRMS)

Belarus, Ukraine, Georgia, Croatia, Moldova, Republic of, Poland, Serbia
Apsen Farmaceutica S.A.

Terminated

Phase III Efficacy and Tolerability Trial of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus Isolated Active Substances in Pain Control After Impacted Third Molar Extraction (FDCETCB-III)

Pain, Acute

Brazil
Apsen Farmaceutica S.A.

Withdrawn

Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS

Hyperplasia

Brazil
Aquilon Pharmaceuticals S.A.

Terminated

Clinical Trial to Assess the Efficacy and Safety of Inhaled AQ001S in the Management of Acute COVID-19 Symptoms (SIROCCO-1)

Covid19

Belgium
Ferrer Internacional S.A.

Available

Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung Disease

Pulmonary Hypertension | Interstitial Lung Disease | Combined Pulmonary Fibrosis and Emphysema
ADC Therapeutics S.A.

Withdrawn

Long-term Registry of Patients Treated With Loncastuximab Tesirine

B-Cell Lymphomas

United States
Laboratorios Andromaco S.A.

Completed

Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

Therapeutic Equivalency

India
Laboratorios Andromaco S.A.

Completed

Bioavailability of Eszopiclone 3.0 mg With Regards to Reference Product

Bioequivalence

India
ADC Therapeutics S.A.

Withdrawn

A Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Antitumor Activity of Loncastuximab Tesirine in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated Diffuse Large B-cell Lymphoma (LOTIS-8) (LOTIS-8)

Diffuse Large B-Cell Lymphoma

United States
Laboratorios Andromaco S.A.

Completed

Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product

Bioequivalence

India
Eurofarma Laboratorios S.A.

Completed

UFH is the Most Used Anticoagulant in Hemodialysis, Decreasing the Risk of Clot Formation in the Circuit. (HEPIRC)

Hemodialysis Complication
Laboratorios Andromaco S.A.

Completed

Bioavailability of Oseltamivir Phosphate 75 mg With Regards to Reference Product

Bioequivalence

India
ADC Therapeutics S.A.

Terminated

Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma

Follicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma

Spain, United States
Laboratorios Andromaco S.A.

Completed

Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product

Bioequivalence

Chile
Amyndas Pharmaceuticals S.A.

Completed

A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis

Gingivitis

United States
Laboratorios Andromaco S.A.

Completed

Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

Bioequivalence

Chile
ADC Therapeutics S.A.

Terminated

Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression

Breast Cancer | Non Small Cell Lung Cancer | Bladder Cancer | GastroEsophageal Cancer

United States, Belgium
Steba Biotech S.A.

Withdrawn

Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer

Localized Prostate Cancer

United States
Laboratorios Andromaco S.A.

Completed

Bioavailability of Clotiazepam 5 mg With Regards to Reference Product

Bioequivalence

Chile
Bone Therapeutics S.A

Terminated

Study on Autologous Osteoblastic Cells Implantation in Hypotrophic Non-Union Fractures

Long Bone Non-Union

Belgium, France, Netherlands
Bone Therapeutics S.A

Terminated

Study on Allogeneic Osteoblastic Cells Implantation in Rescue Interbody Fusion

Failed Lumbar Fusion

Belgium
OASIS Diagnostics S.A.

Completed

Impedance Spectroscopy in Detection of Obstetric Anal Sphincter Injuries

Delivery, Obstetric | Obstetric Anal Sphincter Injury

Poland
Glenmark Specialty S.A.

Completed

Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR) (GSP 301-303)

Perennial Allergic Rhinitis

United States
ADC Therapeutics S.A.

Terminated

Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia

United States
Eurofarma Laboratorios S.A.

Completed

Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL) (GLACIAL)

Osteoarthritis of Knee

Brazil
Steba Biotech S.A.

Completed

Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance. (PCM301)

Prostate Cancer

Spain, France, Germany, Netherlands, United Kingdom, Belgium, Finland, Italy, Sweden, Switzerland
Almirall, S.A.
Allergan

Completed

Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Acne Vulgaris

United States
Almirall, S.A.
Allergan

Completed

Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Acne Vulgaris

United States
Almirall, S.A.
Allergan

Completed

A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
HTL-Strefa S.A.

Completed

Capillary Blood Volume and Pain Perception Obtained in a Process of Puncturing With Different Safety Lancets

Healthy

Poland

3

Subscribe